Enflurane analgesia in obstetrics

Area of Science:

• Obstetrics and Gynecology
• Anesthesiology
• Neonatal Care

Background:

• Pain management during labor is crucial for maternal and neonatal outcomes.
• Evaluating the safety and efficacy of different anesthetic agents is essential for clinical practice.
• Enflurane and nitrous oxide are commonly used analgesics in obstetric anesthesia.

Purpose of the Study:

• To compare the efficacy and safety of enflurane analgesia with nitrous oxide during vaginal delivery.
• To assess maternal satisfaction, anesthesiologist and obstetrician ratings, and neonatal well-being.
• To evaluate potential maternal and neonatal toxicity, specifically serum inorganic fluoride levels.

Main Methods:

• A comparative study involving 55 patients receiving enflurane (0.5%) and oxygen versus 50 patients receiving nitrous oxide (40%) during the second stage of vaginal delivery.
• Maternal satisfaction, anesthesiologist, and obstetrician ratings were collected.
• Neonatal status was assessed using Apgar scores and cord blood gas tensions; maternal and neonatal serum inorganic fluoride levels were measured.

Main Results:

• Maternal and anesthesiologist satisfaction ratings for enflurane were comparable to nitrous oxide.
• Obstetricians rated enflurane superior to nitrous oxide.
• Both agents resulted in vigorous newborns with similar Apgar scores and cord blood gases, comparable blood loss, and no significant increase in maternal serum inorganic fluoride or biochemical evidence of renal toxicity. Neonatal fluoride levels were below nephrotoxic thresholds.

Conclusions:

• Enflurane analgesia is a safe and effective alternative to nitrous oxide for vaginal delivery.
• Both agents demonstrate favorable maternal and neonatal outcomes with no significant toxicity.
• Obstetrician preference for enflurane suggests potential advantages in clinical application.